Lupin gets USFDA nod to generic equivalent of Tecfidera Delayed-Release Capsules Ruchika Sharma7 Oct 2020 12:31 PM ISTMumbai, Baltimore: Pharma major, Lupin Limited, has recently announced that the company has received approval for its Dimethyl Fumarate...
Dr Reddys unveils multiple sclerosis drug Dimethyl Fumarate Delayed-Release Capsules Ruchika Sharma28 Sept 2020 3:30 PM ISTHyderabad and Princeton: Dr. Reddy's Laboratories Ltd. has recently announced the launch of Dimethyl Fumarate Delayed-Release Capsules, a therapeutic ...
Cipla gets USFDA nod for Dimethyl Fumarate DR Capsules to treat multiple sclerosis Ruchika Sharma27 Sept 2020 10:00 AM ISTMumbai: Drugmaker, Cipla Limited, has recently announced that the company has received final approval for its Abbreviated New Drug Application...
Zydus Cadila gets USFDA nod for multiple sclerosis drug Ruchika Sharma26 Sept 2020 10:00 AM ISTAhmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received final approval from the U.S. Food and Drug...
Adolescent obesity and smoking linked to Multiple sclerosis risk: study Dr Satabdi Saha8 Sept 2020 6:00 PM ISTAccording to a recent research report, teen and adolescent obesity and other lifestyle habits such as smoking may affect the chances of developing...
Mylan launches generic Tecfidera for treatment of Multiple Sclerosis Ruchika Sharma21 Aug 2020 1:32 PM ISTHertfordshire and Pittsburgh: Mylan N.V. has announced the launch of the first FDA-approved therapeutically equivalent,...
Cashew shell compound may reverse demyelination in MS: Study Hina Zahid21 Aug 2020 8:45 AM ISTMany neurological disorders stem from damage to myelin, the insulating material which wraps around nerves and provides optimal nerve conduction. We...
Arzerra associated with lower relapse rate in multiple sclerosis patients: ASCLEPIOS trial Medha Baranwal9 Aug 2020 3:00 PM ISTUSA: Ofatumumab lowers relapse rate in patients with multiple sclerosis as compared to teriflunomide, suggests a recent study in the New England...
Exercise and lifestyle physical activity recommendations for MS patients Dr. Kamal Kant Kohli26 July 2020 2:15 PM ISTThe National MS Society has released exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the...
'Breakthrough' treatment slashes virus death risk: study Hina Zahid25 July 2020 8:15 AM ISTAn aerosol-based drug treatment could drastically reduce the number of new coronavirus patients dying from the disease or requiring intensive care,...
Hookworm treatment offers hope for recurring multiple sclerosis Dr. Kamal Kant Kohli19 Jun 2020 9:00 AM ISTResearchers at University of Nottingham have found in a new study that parasitic worms could offer a new treatment hope for patients suffering from...
New antibody technology for monitoring MS patients may have potential in COVID-19 testing Dr. Kamal Kant Kohli5 Jun 2020 5:00 AM ISTA new study led by Queen Mary University of London has demonstrated the effectiveness of using a novel light technology to monitor the presence of...
